DK189189D0 - AZELASTIC CONTAINED ACTIVE SUBSTANCES WITH CONTROLS - Google Patents
AZELASTIC CONTAINED ACTIVE SUBSTANCES WITH CONTROLSInfo
- Publication number
- DK189189D0 DK189189D0 DK189189A DK189189A DK189189D0 DK 189189 D0 DK189189 D0 DK 189189D0 DK 189189 A DK189189 A DK 189189A DK 189189 A DK189189 A DK 189189A DK 189189 D0 DK189189 D0 DK 189189D0
- Authority
- DK
- Denmark
- Prior art keywords
- azelastic
- controls
- azelastine
- active substances
- release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Abstract
Azelastine-containing pharmaceutical compositions with controlled release of active substance using a release-delaying component, there being 0.001 to 800 parts of release-delaying component for one part by weight of azelastine (as base), and it also being possible for the azelastine to be in the form of its physiologically tolerated salts, and the rate of azelastine release being between 0.05 and 5 mg per hour.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3813244 | 1988-04-20 | ||
DE3813244 | 1988-04-20 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK189189D0 true DK189189D0 (en) | 1989-04-19 |
DK189189A DK189189A (en) | 1989-10-21 |
DK172235B1 DK172235B1 (en) | 1998-02-02 |
Family
ID=6352451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK189189A DK172235B1 (en) | 1988-04-20 | 1989-04-19 | Azelastine-containing controlled-release drug |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0338444B1 (en) |
JP (1) | JP2950845B2 (en) |
AT (1) | ATE97572T1 (en) |
AU (1) | AU3318389A (en) |
CA (1) | CA1325976C (en) |
DE (1) | DE58906232D1 (en) |
DK (1) | DK172235B1 (en) |
ES (1) | ES2060685T3 (en) |
FI (1) | FI891865A (en) |
HK (1) | HK134494A (en) |
HU (1) | HU202403B (en) |
IE (1) | IE62778B1 (en) |
MC (1) | MC2025A1 (en) |
PT (1) | PT90308B (en) |
ZA (1) | ZA892877B (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9003903D0 (en) * | 1990-12-07 | 1990-12-07 | Astra Ab | NEW PHARMACEUTICAL FORMULATIONS |
DE4207234A1 (en) * | 1992-03-07 | 1993-09-09 | Asta Medica Ag | NEW AMINOCARBONIC ACID DERIVATIVES WITH ANTIALLERGIC / ANTIASTHMIC EFFECT AND METHOD FOR THE PRODUCTION THEREOF |
JPH0710747A (en) * | 1993-04-28 | 1995-01-13 | Takeda Chem Ind Ltd | Solid preparation and its production |
GB9514842D0 (en) * | 1995-07-20 | 1995-09-20 | Smithkline Beecham Plc | Novel formulation |
JP4138910B2 (en) * | 1997-07-02 | 2008-08-27 | 帝國製薬株式会社 | Transdermal preparation containing azelastine hydrochloride with good transdermal absorbability and low skin irritation |
UA67802C2 (en) * | 1998-10-23 | 2004-07-15 | Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. | CONTROLLED-RELEASE FORMULATIONS FOR ORAL ADMINISTRATION CONTAINING cGMP PDE-5 INHIBITOR (VARIANTS), METHOD FOR ITS PREPARATION AND METHOD FOR TREATING ERECTILE DYSFUNCTION |
PT1126826E (en) | 1998-11-02 | 2008-11-25 | Elan Pharma Int Ltd | Multiparticulate modified release composition of methylphenidate |
KR101476574B1 (en) | 1999-10-29 | 2014-12-24 | 유로-셀티크 소시에떼 아노뉨 | Controlled release hydrocodone formulations |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
MXPA03003895A (en) | 2000-10-30 | 2003-07-28 | Euro Celtique Sa | Controlled release hydrocodone formulations. |
EP1396263A1 (en) * | 2002-08-09 | 2004-03-10 | Warner-Lambert Company | Film coating for tablets and caplets |
CA2510320C (en) * | 2002-12-20 | 2012-10-09 | St. James Associates Llc/Faber Research Series | Coated particles for sustained-release pharmaceutical administration |
EP2486942B1 (en) * | 2004-11-24 | 2018-10-10 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
AU2014235854B2 (en) | 2013-03-21 | 2019-04-11 | Eupraxia Pharmaceuticals USA LLC | Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith |
PL3206672T3 (en) | 2015-10-27 | 2018-09-28 | Eupraxia Pharmaceuticals Inc. | Sustained release formulations of local anesthetics |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3575135D1 (en) * | 1984-09-14 | 1990-02-08 | Asta Pharma Ag | SUBSTITUTED BENZYLPHTHALAZINONE DERIVATIVES. |
-
1989
- 1989-04-11 MC MC892044A patent/MC2025A1/en unknown
- 1989-04-14 DE DE89106685T patent/DE58906232D1/en not_active Expired - Lifetime
- 1989-04-14 EP EP89106685A patent/EP0338444B1/en not_active Expired - Lifetime
- 1989-04-14 ES ES89106685T patent/ES2060685T3/en not_active Expired - Lifetime
- 1989-04-14 AT AT89106685T patent/ATE97572T1/en not_active IP Right Cessation
- 1989-04-19 HU HU891912A patent/HU202403B/en not_active IP Right Cessation
- 1989-04-19 IE IE126389A patent/IE62778B1/en not_active IP Right Cessation
- 1989-04-19 PT PT90308A patent/PT90308B/en not_active IP Right Cessation
- 1989-04-19 AU AU33183/89A patent/AU3318389A/en not_active Abandoned
- 1989-04-19 DK DK189189A patent/DK172235B1/en not_active IP Right Cessation
- 1989-04-19 ZA ZA892877A patent/ZA892877B/en unknown
- 1989-04-19 FI FI891865A patent/FI891865A/en not_active Application Discontinuation
- 1989-04-19 CA CA000597169A patent/CA1325976C/en not_active Expired - Lifetime
- 1989-04-20 JP JP1099031A patent/JP2950845B2/en not_active Expired - Lifetime
-
1994
- 1994-12-01 HK HK134494A patent/HK134494A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK172235B1 (en) | 1998-02-02 |
EP0338444B1 (en) | 1993-11-24 |
PT90308A (en) | 1989-11-10 |
DE58906232D1 (en) | 1994-01-05 |
FI891865A (en) | 1989-10-21 |
AU3318389A (en) | 1989-10-26 |
MC2025A1 (en) | 1990-04-25 |
ATE97572T1 (en) | 1993-12-15 |
ES2060685T3 (en) | 1994-12-01 |
CA1325976C (en) | 1994-01-11 |
DK189189A (en) | 1989-10-21 |
JP2950845B2 (en) | 1999-09-20 |
EP0338444A1 (en) | 1989-10-25 |
IE62778B1 (en) | 1995-02-22 |
ZA892877B (en) | 1989-12-27 |
IE891263L (en) | 1989-10-20 |
FI891865A0 (en) | 1989-04-19 |
PT90308B (en) | 1994-10-31 |
HUT49808A (en) | 1989-11-28 |
HU202403B (en) | 1991-03-28 |
JPH01311024A (en) | 1989-12-15 |
HK134494A (en) | 1994-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK189189A (en) | AZELASTIC CONTAINED ACTIVE SUBSTANCES WITH CONTROLS | |
DK0449247T3 (en) | Pharmaceutical formulation containing galanthamine for the treatment of alcoholism | |
ATE76747T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING LEVODOPA METHYL ESTER, THEIR PREPARATION AND THERAPEUTIC USES. | |
PT615754E (en) | SOLID FORMS OF CONTROLLED LIBERATION ORAL ADMINISTRATION FLUPERTINE | |
GR1003711B (en) | Method for preparating pharmaceutical compositions for diadermic use | |
DK367687D0 (en) | PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION WITH REGULATED DELIVERY AND EXTENDED EFFECT | |
DK1308170T3 (en) | Dried blood factor preparation containing trehalose | |
ATE148630T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING STABILIZED DERIVATIVES OF VITAMIN D2 AND D3 | |
DK373187A (en) | MEDICINAL WITH SLOW RELEASE OF THE ACTIVE INGREDIENT | |
DK0458588T3 (en) | Treatment of ocular hypertension with a synergistic combination for ocular administration | |
NO821084L (en) | PROCEDURE FOR PREPARING GALENIC PREPARATION WITH CONSTANT ACTUAL RELEASE | |
DK386986A (en) | INJECTABLE semi-solid pharmaceutical formulation with slow release of the active ingredient | |
DK122191A (en) | BENZIMIDAZOLD DERIVATIVES AND PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF, AND PROCEDURES FOR THE PREPARATION OF SAME | |
DE3783923T3 (en) | A drug containing an active ingredient and a water-swelling polymer. | |
EP0380989A3 (en) | Plaster for transdermal administration | |
ES2043719T3 (en) | DRUG ADMINISTRATION BY VIA PERCUTANEA. | |
EP0351876A3 (en) | Composition for potentiating vaccination effect | |
DK0521353T3 (en) | Antineoplastic drug containing octadecyl (2- (N-methylpiperidino) ethyl) phosphate as an active ingredient and process for its preparation | |
TH7154EX (en) | Celastine contained in therapeutic agents that regulate the release of active metabolites. | |
DK0560207T3 (en) | Preparation for oral use based on ibuprofen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PUP | Patent expired |